(Q35953824)

English

Generation and Characterization of a Human/Mouse Chimeric GD2-Mimicking Anti-Idiotype Antibody Ganglidiximab for Active Immunotherapy against Neuroblastoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 August 2017

Generation and Characterization of a Human/Mouse Chimeric GD2-Mimicking Anti-Idiotype Antibody Ganglidiximab for Active Immunotherapy against Neuroblastoma (English)

1 reference

Europe PubMed Central

11 August 2017

1 reference

based on heuristic

inferred from title

object named as

Holger N Lode

8

0 references

author name string

Christin Eger

1

1 reference

Europe PubMed Central

11 August 2017

Nikolai Siebert

2

1 reference

Europe PubMed Central

11 August 2017

Diana Seidel

3

1 reference

Europe PubMed Central

11 August 2017

Maxi Zumpe

4

1 reference

Europe PubMed Central

11 August 2017

Madlen Jüttner

5

1 reference

Europe PubMed Central

11 August 2017

Sven Brandt

6

1 reference

Europe PubMed Central

11 August 2017

Hans-Peter Müller

7

1 reference

Europe PubMed Central

11 August 2017

language of work or name

0 references

publication date

11 March 2016

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

11

1 reference

Europe PubMed Central

11 August 2017

3

1 reference

Europe PubMed Central

11 August 2017

e0150479

1 reference

Europe PubMed Central

11 August 2017

copyright license

Creative Commons Attribution 4.0 International

11 March 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Disialoganglioside-specific human natural killer cells are effective against drug-resistant neuroblastoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788445

2 October 2017

Functional bioassays for immune monitoring of high-risk neuroblastoma patients treated with ch14.18/CHO anti-GD2 antibody

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788445

2 October 2017

Gene expression in Mammalian cells and its applications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788445

2 October 2017

Ch14.18 antibody produced in CHO cells in relapsed or refractory Stage 4 neuroblastoma patients: a SIOPEN Phase 1 study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788445

2 October 2017

Vaccination with anti-idiotype antibody ganglidiomab mediates a GD(2)-specific anti-neuroblastoma immune response.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788445

2 October 2017

Promising therapeutic targets in neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788445

2 October 2017

NK cells engineered to express a GD2 -specific antigen receptor display built-in ADCC-like activity against tumour cells of neuroectodermal origin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788445

2 October 2017

Anti-GD2 Strategy in the Treatment of Neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788445

2 October 2017

Vaccine adjuvants: putting innate immunity to work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788445

2 October 2017

Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788445

2 October 2017

Characterization of GD2 peptide mimotope DNA vaccines effective against spontaneous neuroblastoma metastases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788445

2 October 2017

Genetics of somatic mammalian cells. III. Long-term cultivation of euploid cells from human and animal subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788445

2 October 2017

Human antiglobulin response to foreign antibodies: therapeutic benefit?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788445

2 October 2017

Anti-idiotype antibody vaccine therapy for cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788445

2 October 2017

Targeted interleukin-2 therapy for spontaneous neuroblastoma metastases to bone marrow

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788445

2 October 2017

Anti-idiotype cancer vaccines: past and future

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788445

2 October 2017

T cell-independent antigens type 2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788445

2 October 2017

Towards a network theory of the immune system.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788445

2 October 2017

Serum half-life and tumor localization of a chimeric antibody deleted of the CH2 domain and directed against the disialoganglioside GD2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788445

2 October 2017

Antibody-targeted interleukin 2 stimulates T-cell killing of autologous tumor cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788445

2 October 2017

Anti-GD(2) with an FC point mutation reduces complement fixation and decreases antibody-induced allodynia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788445

11 July 2018

Targeting of ganglioside GD2 monoclonal antibody to neuroblastoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788445

11 July 2018

Functional properties and effect on growth suppression of human neuroblastoma tumors by isotype switch variants of monoclonal antiganglioside GD2 antibody 14.18.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788445

11 July 2018

Morphology, growth, chromosomal pattern and fibrinolytic activity of two new human neuroblastoma cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788445

11 July 2018

Phase I clinical trial on adjuvant active immunotherapy of human gliomas with GD2-conjugate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788445

24 September 2018

Detection of ganglioside GD2 in tumor tissues and sera of neuroblastoma patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4788445

24 September 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0150479

21 January 2018

Gangliosides and allied glycosphingolipids in human peripheral nerve and spinal cord

1 reference

https://pubmed.ncbi.nlm.nih.gov/26967324

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-level expression of chimeric antibodies using adapted cDNA variable region cassettes

1 reference

https://pubmed.ncbi.nlm.nih.gov/26967324

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of IgG antibodies by an anti-idiotype antibody mimicking disialoganglioside GD2

1 reference

https://pubmed.ncbi.nlm.nih.gov/26967324

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of cellular immunity by anti-idiotypic antibodies mimicking GD2 ganglioside

1 reference

https://pubmed.ncbi.nlm.nih.gov/26967324

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0150479

1 reference

Europe PubMed Central

11 August 2017

2016PLoSO..1150479E

0 references

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35953824&oldid=1970003306"